Talk:Nilotinib
Add topicLatest comment: 10 years ago by Rod57 in topic How does cost compare to imatinib ?
| This is the talk page for discussing improvements to the Nilotinib article. This is not a forum for general discussion of the subject of the article. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Nilotinib.
|
Page should be updated to indicate the completion of the Phase 1 trial for Parkinsons and to indicate its success. Could also be updated to show that a trial is underway for using the drug for ALS patients with similar initial results to the Parkinsons trial. 162.221.255.140 (talk) 20:43, 2 November 2015 (UTC) Nov 2 2015
How does cost compare to imatinib ?
[edit]- since there was controversy about the high of imatinib and Dasatinib. - Rod57 (talk) 12:10, 18 January 2016 (UTC)